1. Home
  2. APRE vs CMCT Comparison

APRE vs CMCT Comparison

Compare APRE & CMCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aprea Therapeutics Inc.

APRE

Aprea Therapeutics Inc.

HOLD

Current Price

$0.63

Market Cap

11.5M

Sector

Health Care

ML Signal

HOLD

Logo Creative Media & Community Trust Corporation

CMCT

Creative Media & Community Trust Corporation

HOLD

Current Price

$2.61

Market Cap

12.8M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
APRE
CMCT
Founded
2006
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
12.8M
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
APRE
CMCT
Price
$0.63
$2.61
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$4.10
N/A
AVG Volume (30 Days)
57.0K
19.6K
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
21.22
N/A
EPS
N/A
N/A
Revenue
N/A
$116,669,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$0.06
52 Week High
$1.93
$14.41

Technical Indicators

Market Signals
Indicator
APRE
CMCT
Relative Strength Index (RSI) 40.85 36.84
Support Level $0.57 $2.16
Resistance Level $0.83 $3.71
Average True Range (ATR) 0.06 0.26
MACD -0.01 -0.02
Stochastic Oscillator 34.44 29.48

Price Performance

Historical Comparison
APRE
CMCT

About APRE Aprea Therapeutics Inc.

Aprea Therapeutics Inc is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers. It develops small molecule inhibitors designed to exploit genetic mutations in cancer to widen the therapeutic window and is intended to make treatments more effective at destroying cancer cells while sparing healthy tissue. The company's pipeline of clinical and preclinical programs includes APR-1051, a WEE1 inhibitor; ATRN-119 (Mosipasertib), an oral small molecule inhibitor of ataxia telangiectasia and Rad3-related, or ATR; and an early-stage program, APR-1602. These candidates are being developed for broad applications in cancer treatment.

About CMCT Creative Media & Community Trust Corporation

Creative Media & Community Trust Corp is a Maryland corporation and REIT. It mainly acquires, develops, owns, and operates both multifamily properties situated in vibrant communities throughout the United States and Class A and creative office real assets in markets with similar business and employment characteristics to multifamily investments. All of its communities are located in areas that include traditional downtowns and suburban main streets, which have high barriers to entry, high population density, positive population trends, and a propensity for growth. Currently, the company consists of three types of commercial real estate properties, namely office, hotel, and multifamily.

Share on Social Networks: